EUVIMEDEUVIMED entdecken
Crossref

Argatroban mitigates Klebsiella pneumoniae liver injury by attenuating ZBP1-dependent PANoptosis

Hongguang Wang, Lulu Chen, Hairui Wang, Zhihui Chang

International Immunopharmacology · 2026-11 · 189 · 117429

DOI: 10.1016/j.intimp.2026.117429 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-11. Verfasst von Hongguang Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital & Institute), Shenyang, China. Hauptthemen laut MEDLINE: Sulfonamides, Klebsiella pneumoniae, Klebsiella Infections, Arginine. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Klebsiella pneumoniae (K. pneumoniae) liver abscess (KPLA) is frequently accompanied by thrombophlebitis and systemic inflammation. Argatroban, a direct thrombin inhibitor, has anti-inflammatory potential, but its efficacy and mechanism in KPLA remain unclear. METHODS: A murine KPLA model was established using a hypervirulent, patient-derived K. pneumoniae strain, with mice receiving vehicle or argatroban (10 mg kg-1/day, i.p.). Survival, liver pathology, vascular permeability, inflammatory responses, and transcriptomic changes were evaluated. Hepatocyte responses were investigated using KP-LPS-stimulated THLE-2 cells. ZBP1 localization, protein interactions, and functional dependence were assessed by immunofluorescence, co-immunoprecipitation, and ZBP1 silencing. RESULTS: Argatroban significantly improved 72-h survival (P = 0.02), reduced hepatic necrosis, attenuated sinusoidal vascular leakage, and suppressed systemic inflammatory cytokine production in KPLA mice. RNA-seq revealed activation of innate immune-sensing pathways during infection, which were markedly attenuated by argatroban. ZBP1 and PANoptosis-associated molecules were increased in KPLA livers and reduced by argatroban. ZBP1 was predominantly localized in hepatocytes. In KP-LPS-stimulated THLE-2 cells, RIPK3, ASC, and Caspase-8 showed enhanced intracellular co-localization, while co-immunoprecipitation demonstrated ZBP1 interactions with RIPK3, ASC, and Caspase-8. ZBP1 silencing markedly reduced KP-LPS-induced activation of p-MLKL, cleaved GSDMD, and cleaved caspase-3, supporting ZBP1-dependent PANoptosis as a key driver of hepatocyte inflammatory injury. Mechanistically, argatroban inhibited TLR4 endocytosis and downstream TBK1/IRF3-STAT1 signaling, thereby suppressing ZBP1 induction. CONCLUSIONS: Argatroban protects against KPLA-associated liver injury by inhibiting a TLR4 endocytosis-TBK1/IRF3-STAT1-ZBP1 axis and suppressing ZBP1-dependent PANoptosis, identifying PANoptosis as a potential therapeutic target in severe K. pneumoniae infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfonamidesKlebsiella pneumoniaeKlebsiella InfectionsArgininePipecolic AcidsRNA-Binding ProteinsAnti-Inflammatory AgentsAnimalsMiceLiverHumansMice, Inbred C57BLMaleDisease Models, AnimalNecroptosisHepatocytes

Stichwörter der Autor:innen

ArgatrobanKlebsiella pneumoniae liver abscessPANoptosisTLR4 endocytosisZBP1

Substanzen

SulfonamidesargatrobanArgininePipecolic AcidsRNA-Binding ProteinsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Interventional Radiology, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital & Institute), Shenyang, China.
  • Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address: wanghr@sj-hospital.org.
  • Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address: zhchang@cmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, H., Chen, L., Wang, H., & Chang, Z. (2026). Argatroban mitigates Klebsiella pneumoniae liver injury by attenuating ZBP1-dependent PANoptosis. International Immunopharmacology, 189, 117429. https://doi.org/10.1016/j.intimp.2026.117429

Vancouver

Wang H, Chen L, Wang H, Chang Z. Argatroban mitigates Klebsiella pneumoniae liver injury by attenuating ZBP1-dependent PANoptosis. International Immunopharmacology. 2026;189:117429. doi:10.1016/j.intimp.2026.117429

BibTeX
@article{Wang2026,
  author = {Wang, Hongguang and Chen, Lulu and Wang, Hairui and Chang, Zhihui},
  title = {Argatroban mitigates Klebsiella pneumoniae liver injury by attenuating ZBP1-dependent PANoptosis},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {189},
  pages = {117429},
  doi = {10.1016/j.intimp.2026.117429}
}
Kostenlos starten →